SEC Rule 10b5-1, codified at 17 CFR 240.10b5-1, is a regulation enacted by the United States Securities and Exchange Commission in 2000. From Wikipedia
Dale Chappell, former Chief Scientific Officer of Humanigen, allegedly exploited nonpublic FDA information to avoid stock losses.
